CX-516

CX516 is an ampakine compound that works as an AMPA modulator and is being devolped by a collaboration of Cortex and Shire and Servier. It is being pursued as a treatment for Alzheimer's disease, under the brand name Ampalex. It is also being examined as a treatment for ADHD. The CAS number of this compound is 154235-83-3.